Cargando…
Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis
BACKGROUND: Sarcopenia is the loss of skeletal muscle mass and function that occurs with advancing age and certain diseases. It is thought to have a negative impact on survival in cancer patients. Routine computed tomography imaging is often used to quantify skeletal muscle in cancer patients. Sarco...
Autores principales: | Ubachs, Jorne, Ziemons, Janine, Minis‐Rutten, Iris J.G., Kruitwagen, Roy F.P.M., Kleijnen, Jos, Lambrechts, Sandrina, Olde Damink, Steven W.M., Rensen, Sander S., Van Gorp, Toon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903439/ https://www.ncbi.nlm.nih.gov/pubmed/31389674 http://dx.doi.org/10.1002/jcsm.12468 |
Ejemplares similares
-
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
por: Rutten, Iris J.G., et al.
Publicado: (2017) -
Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients
por: Ubachs, Jorne, et al.
Publicado: (2021) -
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
por: Rutten, Iris J.G., et al.
Publicado: (2016) -
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
por: Ubachs, Jorne, et al.
Publicado: (2021) -
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
por: Laven, Pim, et al.
Publicado: (2021)